Company profile: Twist Bioscience
1.1 - Company Overview
Company description
- Provider of synthetic DNA solutions using a semiconductor-based platform for high-throughput, cost-effective manufacturing; customizable gene synthesis; variant libraries; NGS target enrichment panels for viral genome detection and characterization; synthetic RNA controls for diagnostic quality assurance; antibody development against SARS-CoV-2; and comprehensive viral research panels.
Products and services
- Gene Synthesis: Twist architects custom-engineered gene synthesis services, delivering customizable DNA sequences tailored to specific researcher needs
- NGS Target Enrichment Panels: Twist produces NGS-optimized panels used to detect and characterize viral genomes, including SARS-CoV-2, through next-generation sequencing
- Synthetic DNA Manufacturing: Twist Bioscience engineers synthetic DNA using a semiconductor-based platform, enabling high-throughput and cost-effective manufacturing of synthetic DNA solutions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Twist Bioscience
Athenix
HQ: United States
Website
- Description: Provider of crop science offerings in seeds, crop protection, and non-agricultural pest control, leveraging agricultural and industrial biotechnology and a gene-discovery infrastructure to develop products that meet real customer needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Athenix company profile →
Cygnus Technologies
HQ: United States
Website
- Description: Provider of generic kits, immunoassay reagents, and antibody and assay development services to pharmaceutical and biotechnology industries. Specializes in custom antibody and assay development for host cell protein detection in recombinant pharmaceuticals and supplies specialized analytical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cygnus Technologies company profile →
Exiqon
HQ: Denmark
Website
- Description: Provider of Life Sciences and Diagnostics solutions, offering flexible RNA analysis research products used by academia, biotech and pharmaceutical companies worldwide to investigate gene activity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Exiqon company profile →
Chromatin
HQ: United States
Website
- Description: Provider of plant breeding and genomics technologies for agricultural, energy, chemical, nutritional and pharmaceutical sectors. Develops sorghum for agriculture and renewable energy, and advances maize and wheat via high-yielding, disease- and climate-resilient traits. Services include genomic selection, high-throughput phenotyping, multi-trait analysis, environics for genotype prediction, and integrated genomics-phenomics modeling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chromatin company profile →
QuantuMDx
HQ: United Kingdom
Website
- Description: Provider of handheld and portable low-cost diagnostic and genomic sequencing platforms, including the Q-POC rapid multiplex PCR point-of-care system; assays for SARS-CoV-2, Flu A/B, RSV; a research-use TB host immune response assay; a saliva-based SARS-CoV-2 RT-PCR test; CAPTURE-XT lab-on-chip pathogen concentration; and microarray technologies for high-throughput genetic marker screening.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QuantuMDx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Twist Bioscience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Twist Bioscience
2.2 - Growth funds investing in similar companies to Twist Bioscience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Twist Bioscience
4.2 - Public trading comparable groups for Twist Bioscience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →